A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

Clinical trial NCT05083481 · TERMINATED

Trial details

NCT number: NCT05083481
Sponsor: Astellas Pharma Global Development, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2021-10-19
Primary completion: 2026-05-11
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.